However, in deceased individuals, the ratio showed an opposite tendency.<h4>Conclusion</h4>The determination of the tissue BDNF/MMP9 ratio can be used as a prognostic biomarker of CRC. This evidence concerns the gene MMP9 and colorectal carcinoma.